Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 0093-1921

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0093-1921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure diagram of Cyclobenzaprine Hydrochloride shown with its molecular configuration, including its ring system and chemical groups as depicted in the image.*

FDA Label Image

Cyclobenzaprine Hydrochloride Extended-release Capsules 15 mg, 60s Label (Image 2)

An illustration shows a spoon holding a small heap of a white, granular, or powdery substance. The image suggests the concept of a powdered medication or ingredient on a spoon.*

FDA Label Image

Cyclobenzaprine Hydrochloride Extended-release Capsules 30 mg, 60s Label (Image 3)

An instructional illustration depicting a hand holding an extended-release capsule labeled 'TOP,' showing the correct orientation or handling method for the Cyclobenzaprine Hydrochloride capsule.*

FDA Label Image

Image 4

An instructional diagram showing a hand twisting the cap off a container labeled "TOP." The illustration demonstrates how to open the container by rotating the cap in a specific direction.*

FDA Label Image

Image 5

An instructional illustration showing a hand opening a capsule and emptying small beads or pellets from the capsule onto a spoon. This image likely demonstrates how to administer the contents of an extended-release capsule if needed.*

FDA Label Image

Image 6

Illustration showing a woman using a spoon to take medication orally, highlighting the oral administration method of the drug.*

FDA Label Image

Image 7

An illustration of a woman drinking a glass of water, typically used to demonstrate proper oral ingestion of medication.*

FDA Label Image

Image 8

Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules 15 mg by Teva Pharmaceuticals USA, Inc. The label states the product is prescription-only with a 60 capsule count. It includes dosage information advising adults to take one or two capsules once daily, and safety warnings to keep medications out of reach of children.*

FDA Label Image

Image 9

Label for Cyclobenzaprine Hydrochloride Extended-Release Capsules 30 mg by Teva Pharmaceuticals USA, Inc. The label shows the dosage strength of 30 mg and states the package contains 60 capsules for oral use. It includes dosage instructions, storage information, a barcode, NDC 0093-1921-06, and a section for lot and expiration coding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.